Targeted Funding Opportunities

Targeted Funding Opportunity Announcements

• Technology Development for Single-Molecule Protein Sequencing (PA-21-247)
  This targeted funding opportunity seeks to fund technology development research efforts in instrumentation innovation and sample preparation/processing approaches for single-molecule protein sequencing.

• Development of Highly Innovative Tools and Technology for Analysis of Single Cells (PA-20-047, PA-20-025)
  This targeted funding opportunity is for projects that focus on developing next-generation technologies and tools to better define cell heterogeneity and organization rules. The goal of the funding opportunity is to accelerate the development and translation of the cutting-edge single cell analysis approaches.

• Targeted Funding Opportunities for Commercializing Understudied Proteins (PA-19-034, PA-19-033)
  This Funding Opportunity Announcement aims to provide funding support for small businesses to initiate translational research of understudied proteins identified in the "Illuminating the Druggable Genome" project (IDG; https://commonfund.nih.gov/idg/index).

​

• Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (PA-18-801, PA-18-802)
  This targeted funding opportunity is for small businesses that are developing cancer technologies that can be used in low-resource settings, such as low- and middle-income countries and low-resource settings in the U.S. 
  - SBIR Direct-to-Phase II is now available for PA-18-801. More information available on Guide Notice NOT-CA-19-003.
  - Phase I Budget cap has increased to $400,000. More information available on Guide Notices NOT-CA-19-055 and NOT-CA-19-056. 

• Notice of Special Interest (NOSI): National Cancer Institute SBIR/STTR Program Announcement Regarding Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (NOT-CA-21-062)
  The NCI encourages grant applications from small businesses to develop or adapt, apply, and validate existing or emerging technologies into user-friendly, low-resource setting-appropriate technologies for cancer prevention, diagnosis, or treatment

• Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (PAR-18-303)
  This targeted funding opportunity is for small businesses developing cancer technologies with an emphasis on molecular analysis technologies to improve cancer prevention, detection and diagnosis, surveillance, epidemiological research, and basic cancer research.
  - SBIR Direct-to-Phase II is now available for this funding opportunity announcement. More information available on Guide Notice NOT-CA-19-002.
  - Phase I Budget cap has increased to $400,000. More information available on Guide Notice NOT-CA-19-062.

• SBIR Technology transfer (PA-18-705)
  SBIR only. Funding opportunity for small businesses interested in translating NCI-developed technology from lab to patients.

This page is updated as new funding opportunities are announced. Please visit this page often to view new opportunities. View the NIH SBIR/STTR website for more information on targeted funding opportunities.

You may also sign up to receive email updates from NCI SBIR & STTR Programs announcing new funding opportunities. If you would like to receive updates from the NCI SBIR & STTR Programs, please subscribe to our mailing list.